Litcius/Paper detail

Ivosidenib for advanced IDH1-mutant cholangiocarcinoma – Authors' reply

Ghassan K. Abou‐Alfa, Shuchi S. Pandya, Andrew X. Zhu

2020The Lancet Oncology24 citationsDOI

Topics & Concepts

MedicineIDH1MutantOncologyCancer researchGeneticsGeneBiologyCholangiocarcinoma and Gallbladder Cancer StudiesPancreatic and Hepatic Oncology ResearchChromatin Remodeling and Cancer
Ivosidenib for advanced IDH1-mutant cholangiocarcinoma – Authors' reply | Litcius